Innovating Works

OPEN PHACTS

Financiado
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.
Lider
IMIM
N.D. | Participante
FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL I...
N.D. | Participante
USC
N.D. | Participante
ALMIRALL
N.D. | Participante
ESTEVE PHARMACEUTICALS
N.D. | Participante
OGL
N.D. | Participante
Leiden University Medical Center
N.D. | Participante
DTL PROJECTS
N.D. | Participante
Pfizer RD UK Limited
N.D. | Participante
RSC
N.D. | Participante
UNIVERSITY OF MANCHESTER
N.D. | Participante
STICHTING VU
N.D. | Participante
UNIVIE
N.D. | Participante
NOVARTIS
N.D. | Participante
ASTRAZENECA AB
N.D. | Participante
SIB SWISS INSTITUTE OF BIOINFORMATICS
N.D. | Participante
UNIVERSITEIT MAASTRICHT
N.D. | Participante
UHAM
N.D. | Participante
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
N.D. | Participante
RHEINISCHE FRIEDRICHWILHELMSUNIVERSITAT BONN
N.D. | Participante
H. LUNDBECK AS
N.D. | Participante
The Open PHACTS Foundation
N.D. | Participante
TECHNICAL UNIVERSITY OF DENMARK DTU
N.D. | Participante
Eli Lilly
N.D. | Participante
JANSSEN PHARMACEUTICA NV
N.D. | Participante